TGFB1 and neoplasm: Reduced anti-inflammatory factors (TGF-β, IL-10, VEGF-A) and increased pro-inflammatory factors (IFN-γ, IL-12, TNF-α) in tumors; shifted macrophages from M2 to M1 phenotype, thereby inhibited tumor growth